Octahydrocyclopenta[b]morpholine is used as a reactant in the preparation of novel 4-(substituted amino)-7H-pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors, useful in treating Parkinson's disease.
参考文献
Galatsis, P., et al.: U.S. Pat. Appl. Publ. (2014), US 20140005183 A1 20140102.